OBJECTIVES The aim of this study was to evaluate the prognostic value of cardiac magnetic resonance (CMR) feature-tracking-derived global longitudinal strain (GLS) in a large multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy.
E jection fraction (EF) is the principal measure used in clinical practice to assess cardiac mechanics. It provides significant prognostic information and is used widely for many clinical and therapeutic decisions, particularly in patients with left ventricular (LV) dysfunction. More recently, direct assessment of myocardial fiber deformation with echocardiographic global longitudinal strain (GLS) imaging has shown promise in providing diagnostic and prognostic information that is incremental to EF (1, 2) .
Cardiac magnetic resonance (CMR) imaging has evolved into a major tool for assessment of patients with LV dysfunction, providing precise measurements of EF and tissue characterization with late gadolinium enhancement (LGE) (3) . LGE can help establish the underlying cause of LV dysfunction and is a powerful predictor of adverse cardiovascular outcomes (3) . Recent developments in CMR featuretracking techniques now allow assessment of GLS from standard cine-CMR images (4) .
We have recently reported the prognostic association of GLS with mortality in a small population of mixed cardiomyopathy patients from a single center (5) . However, the prognostic value of GLS in patients with ischemic versus nonischemic cardiomyopathy is unknown. Moreover, the robustness of these associations, as well as the variability of feature-tracking GLS measurements in a multicenter setting, remains unclear. The aim of this study was to evaluate the prognostic value of CMR feature-tracking-derived GLS in a large multicenter population of patients with ischemic and nonischemic cardiomyopathy undergoing CMR at several centers in the United States. CMR ANALYSIS AND GLS ASSESSMENT. The studysite investigators analyzed images on locally available workstations and were blinded to follow-up data.
Delayed enhancement was assessed as described previously (6) (7) (8) (9) Bland-Altman analysis of interobserver repeatability for GLS showed a bias of 0.16%. The 95% limits of agreement were À2.08% to 2.40% ( Figure 2 ). Bland-Altman analysis of intraobserver repeatability for GLS showed a bias of À0.07%. The 95% limits of agreement were À1.59 to 1.45% ( Figure 2 ). EF #35% versus those with EF >35% stratified by the highest and lowest tertiles of GLS shows that mortality was significantly higher in patients in the poorest GLS tertile, irrespective of LVEF ( Figure 4 ). Patients within the poorest GLS tertile and LVEF #35% had significantly reduced survival compared with those patients in the poorest GLS tertile with LVEF >35% (log-rank p ¼ 0.003). However, in patients within the bestpreserved GLS tertile, survival was high and unaffected by LVEF ( Figure 4 ).
LGE extent was significantly associated with all- a significantly increased risk of death (log-rank p ¼ 0.0001) ( Figure 5 ). Kaplan-Meier analysis of patients with LGE versus those without LGE, stratified by the highest and lowest tertiles of GLS, shows that mortality was highest for patients in the poorest GLS tertile, irrespective of LGE ( Figure 6 ). Thus, among patients within the poorest GLS tertile, the presence of LGE did not significantly affect survival (log-rank p ¼ 0.328). Likewise, for patients within the bestpreserved GLS tertile, presence of LGE did not significantly affect survival (log-rank p ¼ 0.379) ( Figure 6 ). Tables 3 and 4 ).
DISCUSSION
This study shows that GLS measured by featuretracking CMR was a powerful independent predictor of mortality in a large multicenter population of Patients are stratified by tertiles of global longitudinal strain (GLS). Long-axis function plays a fundamental role in cardiac mechanics, contributing to ventricular ejection by reducing long-axis LV cavity size as the mitral annulus is pulled toward the apex (11, 12) . CMR has been used to measure the contribution of long-axis function to overall stroke volume in normal subjects, elite athletes, and patients with dilated cardiomyopathy (13) . These studies suggest that as much as 60% of stroke volume may be explained by longaxis function. In diastole, the mitral annulus springs back to its equilibrium position, moving around the column of blood passing through the mitral valve, thus aiding ventricular filling (11, 12) .
Possibly because of their subendocardial location, the more longitudinal myocardial fibers seem to be exquisitely sensitive to disturbance by various pathologies, as evidenced by rapid reduction of mitral annular motion with ischemia induction in experimental models (11) . Patients with ejection fraction (EF) #35% versus those with EF >35% are stratified by the highest and lowest tertiles of global longitudinal strain (GLS). (17, 18) .
CMR FEATURE TRACKING GLS AND PROGNOSIS.
There is a significant and growing body of literature demonstrating the prognostic value of GLS derived We have recently reported the prognostic association of GLS with mortality in 470 patients with mixed cardiomyopathy from a single center (5) . The findings in the current study are consistent with these earlier observations and build on previous data by demonstrating the independent and incremental prognostic value of CMR feature-tracking GLS in a multicenter population with a significantly greater number of patients and hard events. A major strength of our study is that they were made in a large multicenter group of patients with both ischemic and nonischemic dilated cardiomyopathy. Thus, these findings have potentially broad application to these important patient groups and greatly expand the evidence base for using CMR-derived GLS to assess prognosis.
ROLE OF CMR IN ASSESSMENT OF LV DYSFUNCTION.
CMR has evolved into a major tool for diagnosis and prognostic assessment of patients with LV dysfunction by providing data on morphology, function, perfusion, viability, and tissue characterization (3, 7, 8) . It is the reference standard for measurement of ventricular volumes, mass, and function, allowing serial assessment of progression of disease or treatment response in individual patients (3, 7) . CMR tissue characterization can sometimes help establish the underlying cause of LV dysfunction (3, 7) . LGE assessment allows prediction of the likelihood of functional recovery after revascularization, medical therapy, or cardiac resynchronization (3, 7) . In addition, LGE is a powerful predictor of adverse cardiovascular outcome in patients with LV dysfunction (3, 7) . In this study, we have now shown that GLS provides independent prognostic information in patients with LV dysfunction being evaluated by CMR.
Moreover, this was incremental to standard clinical and CMR variables including LGE and EF. How this information will affect clinical care requires further study. However, it is interesting to note that we found that patients with relatively preserved GLS had very few adverse events regardless of whether their EF was above or below 35%. Given that current guidelines recommend implantable cardioverter device (ICD) placement based primarily on an EF #35%, it will be interesting to examine the role of GLS on sudden cardiac death in future studies. that the ultimate result of using specific causes of death as endpoints is that "softness" is introduced into a study that otherwise would be based on the strength of the "hardest" endpoint of all: all-cause mortality. We therefore believe that all-cause mortality is a highly important and valid primary endpoint for this study.
In this study, we prospectively decided to measure GLS only because this measure has the largest and most robust body of prognostic data from echocardiography. Future studies are needed to address the role of feature-tracking-derived radial or circumferential strain.
Phase-sensitive inversion recovery imaging was not used routinely and was not available on all scanners during the study period, which is reflective of realworld practice and Society for Cardiovascular Magnetic Resonance recommendations (25) . In this study, we used a semiquantitative assessment of LGE extent.
There is no current consensus on the best method of
LGE quantification in nonischemic cardiomyopathy (26) . However, semiquantitative visual LGE assessment has been validated prognostically in previous studies of nonischemic cardiomyopathy and is rapidly performed in daily practice in many clinical laboratories (27, 28) . Moreover, we also assessed binary presence or absence of LGE in this study. Presence of
LGE by visual analysis has extensive prognostic validation in nonischemic cardiomyopathy from numerous previous studies (26) . GLS remained an independent predictor of death, regardless of whether
LGE was assessed in a binary or semiquantitative manner.
In similar fashion to echo speckle tracking, there are algorithmic differences among various CMR feature-tracking software platforms, which may result in differing values (4) . Thus, the applicability of our findings to other feature-tracking vendors requires further investigation.
CONCLUSIONS
In this large multicenter study, GLS measured during routine cine-CMR is a powerful independent predictor of mortality in patients with ischemic and nonischemic dilated cardiomyopathy, incremental to common clinical and imaging risk factors including EF and LGE. Each 1% worsening in GLS was associated with an 89.1% increased risk of death, adjusted to clinical and imaging risk factors. To the best of our knowledge, this study is the largest CMR analysis of GLS in patients with LV dysfunction. The total number of hard events (n ¼ 133) in our population is significantly higher than previous CMR studies of GLS, which greatly increases the robustness of our findings. A major strength of these findings is that they were made in a large multicenter group of patients. Thus, these observations have potentially broad application to these important patient groups.
Our findings highlight the role of long-axis function in patients with LV dysfunction and suggest that consideration should be given to measurement of this parameter in these patients. Future studies are warranted to explore the role of CMR featuretracking-derived GLS in clinical decision making for these patients. Feature-Tracking Strain for the Prediction of Death in Cardiomyopathy Patients -2 0 1 8 : ---
